Table 2 Inhibin and Pax8 immunoreactivity in pancreatic serous cystadenoma and metastatic clear cell renal cell carcinoma involving pancreas

Inhibin and Pax8 immunoreactivity in surgical specimen of pancreatic serous cystadenoma

 Inhibin proportion mean (%)

39 (n = 23, range 0–90)

 Inhibin proportion (%)

0

1–5

6–25

26–50

 > 50

5 (22%)

0

5 (22%)

6 (26%)

7 (30%)

 Pax8 proportion mean (%)

0.4 (n = 23, range 0–2)

 Pax8 proportion (%)

0

1–5

6–25

26–50

 > 50

16 (70%)

7 (30%)

0

0

0

Inhibin and Pax8 immunoreactivity in cytology specimen of pancreatic serous cystadenoma

 Inhibin proportion mean (%)

57 (n = 10, range 0–90)

 Inhibin proportion (%)

0

1–5

6–25

26–50

 > 50

1 (10%)

0

0

5 (50%)

4 (40%)

 Pax8 proportion mean (%)

0 (n = 10, range 0–0)

 Pax8 proportion (%)

0

1–5

6–25

26–50

 > 50

10 (100%)

0

0

0

0

Pax8 immunoreactivity in cytology specimen of metastatic clear cell renal cell carcinoma involving pancreas

 Pax8 proportion mean (%)

76 (n = 9, range 50–90)

 Pax8 proportion (%)

0

1–5

6–25

26–50

 > 50

0

0

0

1 (11%)

8 (89%)